The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Arthrotec 75 modified-release tablets



Pfizer Healthcare IrelandPA0822/112/002

Main Information

Trade NameArthrotec 75 modified-release tablets
Active SubstancesDiclofenac sodium
Lactose monohydrate
Misoprostol
Dosage FormModified-release tablet
Licence HolderPfizer Healthcare Ireland
Licence NumberPA0822/112/002

Group Information

ATC CodeM01AB Acetic acid derivatives and related substances
M01AB55 diclofenac, combinations

Status

License statusAuthorised
Licence Issued07/02/1997
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0058-113-021
Interchangeable List DocumentPDF of Interchangeable List
« Back